G-Xpect PSE
- Product NDC
- 43913-407
- 11-digit product format
- 439130407
- Labeler code
- 43913
- Product ID
- 43913-407_689b0cc1-a239-4ead-95be-e59de8951f61
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Dextromethorphan Hydrobromide, Guaifenesin, and Pseudoephedrine Hydrochloride
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- McLaren Medical
- Application
- part341
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2014-02-11
- Marketing end
- 0000-00-00
- Substance
- DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
- Active strength
- 10 mg/5mL; mg/5mL; mg/5mL
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43913-407-16 | G-Xpect PSE | 473 mL in 1 BOTTLE, PLASTIC | LIQUID | 473 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Dextromethorphan Hydrobromide | ACTIVE INGREDIENT | 9D2RTI9KYH | G-XPECT PSE (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [MCLAREN MEDICAL] | 1 | |
| Guaifenesin | ACTIVE INGREDIENT | 495W7451VQ | G-XPECT PSE (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [MCLAREN MEDICAL] | 1 | |
| Pseudoephedrine Hydrochloride | ACTIVE INGREDIENT | 6V9V2RYJ8N | G-XPECT PSE (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [MCLAREN MEDICAL] | 1 | |
| Dextromethorphan | ACTIVE MOIETY | 7355X3ROTS | G-XPECT PSE (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [MCLAREN MEDICAL] | 1 | |
| Guaifenesin | ACTIVE MOIETY | 495W7451VQ | G-XPECT PSE (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [MCLAREN MEDICAL] | 1 | |
| Pseudoephedrine | ACTIVE MOIETY | 7CUC9DDI9F | G-XPECT PSE (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [MCLAREN MEDICAL] | 1 | |
| Citric Acid Monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | G-XPECT PSE (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [MCLAREN MEDICAL] | 1 | |
| Propylene Glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | G-XPECT PSE (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [MCLAREN MEDICAL] | 1 | |
| Saccharin Sodium | INACTIVE INGREDIENT | SB8ZUX40TY | G-XPECT PSE (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [MCLAREN MEDICAL] | 1 | |
| Sodium Benzoate | INACTIVE INGREDIENT | OJ245FE5EU | G-XPECT PSE (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [MCLAREN MEDICAL] | 1 | |
| Sorbitol | INACTIVE INGREDIENT | 506T60A25R | G-XPECT PSE (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [MCLAREN MEDICAL] | 1 | |
| Sucralose | INACTIVE INGREDIENT | 96K6UQ3ZD4 | G-XPECT PSE (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [MCLAREN MEDICAL] | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | G-XPECT PSE (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [MCLAREN MEDICAL] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43913-407 | G-XPECT PSE (DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [MCLAREN MEDICAL] | 1 | Legacy NDC, 1 package rows | 20140429_19ca6998-8419-4da1-bd6f-7f4fd7477e47.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Status |
|---|
| 43913-407-16 | 43913040716 | 473 mL in 1 BOTTLE, PLASTIC | 473 ml | Historical |